Widely regarded as the most innovative, successful biotech firm ever, Amgen led its industry in revenue and sales growth in 2007. Top magazines including Fortune and Industry Week have repeatedly named it one of America's best companies to work for. In Science Lessons, Gordon Binder--CEO and chairman during 1988-2000--describes Amgen's climb to success. Revealing the highs and...(展开全部)

譯者簡介 顧法嚴先生 （一九一七～一九九五）本名世淦，浙江紹興人，中央大學畢業，曾任農復會總務處長，精通英文、梵文、巴利文，為佛教界著名翻譯家。譯有《佛陀的啟示》、《原始佛典選譯》、《禪門三柱》、《射藝中的禪》、《密宗傳統觀音觀想修法》，均交由慧炬出版社發行。在台期間，曾擔任美國佛教會駐臺譯經院副院長，主持英譯《大寶積經》工作。一九七三年定居美國舊金山，一九八八年依妙境長老出家。

How Strategy Works in an Interconnected, Automated World Leaders already know that the classic approach to strategy--analyze, plan, execute--is losing relevance. But they don't yet know what replaces it. As everyone and everything becomes more interconnected and digitized, how do you operate, compete, and win? Ming Zeng, the former Chief of Staff and strategy adviser to Alibaba...(展开全部)

Through a series of case studies, the authors aim to debunk the idea that science is the result of competent theorization, observation and experimentation. They argue that scientific certainty comes from interpreting ambiguous results within an order which the scientists themselves impose.

Harry Collins and Trevor Pinch liken science to the Golem, a creature from Jewish mythology, powerful yet potentially dangerous, a gentle, helpful creature that may yet run amok at any moment. Through a series of intriguing case studies the authors debunk the traditional view that science is the straightforward result of competent theorisation, observation and experimentation. ...(展开全部)

詹姆斯•克尔 ● Fable公司联合创始人，著名的商业顾问、高管教练、作家、演说家，拥有超过25年的从业 经验，一直致力于帮助精英团队创建高绩效文化。 ● 曾与新西兰全黑队、F1车队、英超足球经理、奥运队等世界杰出组织合作，并为汇丰、壳 牌、波音和毕马威等《财富》500强企业提供咨询服务。 毛大庆 ● 优客工场创始人、董事长。“毛线团”公益跑团团长，曾获“中国马拉松年度人物”“CCTV体坛 风云人物”。 ● 著有《永不可及的美好》《无处安放的童年》《城市人居生活质量评价理论及方法研究》 等；译有《鞋狗》《成就斜杠人生》《布隆伯格自传》等。

In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading, at that point the largest g...(展开全部)

In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading, at that point the largest g...(展开全部)

In very recent times humanity has learnt a vast amount about the universe, the past, and itself. But through our remarkable successes in acquiring knowledge we have learned how much we have yet to learn: the science we have, for example, addresses just 5% of the universe; pre-history is still being revealed, with thousands of historical sites yet to be explored; and the new neu...(展开全部)

In very recent times humanity has learnt a vast amount about the universe, the past, and itself. But through our remarkable successes in acquiring knowledge we have learned how much we have yet to learn: the science we have, for example, addresses just 5% of the universe; pre-history is still being revealed, with thousands of historical sites yet to be explored; and the new neu...(展开全部)